Acne vulgaris A: Review of causes and treatment options

Nurse Practitioner

Volumn 38, Issue 10, 2013, Pages 22-31

  Well, Danielle ^a  

^a Dermatology and Laser Surgery   (United States)

Author keywords

Acne vulgaris; Benzoyl peroxide; Comedones; Isotretinoin; Retinoids

Indexed keywords

NON PRESCRIPTION DRUG; PRESCRIPTION DRUG;

ACNE VULGARIS; HUMAN; NURSE PRACTITIONER; PATHOPHYSIOLOGY; PATIENT EDUCATION; REVIEW; SEVERITY OF ILLNESS INDEX;

ACNE VULGARIS; HUMANS; NONPRESCRIPTION DRUGS; NURSE PRACTITIONERS; PATIENT EDUCATION AS TOPIC; PRESCRIPTION DRUGS; SEVERITY OF ILLNESS INDEX;

EID: 84888213159     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000434089.88606.70     Document Type: Review

References (48)

1. Saitta P, Keehan P, Yousif J, Way BV, Grekin S, Brancaccio R. An update on the presence of psychiatric comorbidities in acne patients. Part 1: overview of prevalence. Cutis. 2011; 88(1):33-40.
2. Goulden V, Stables GI, Cunliffe WJ. Prevalence of facial acne in adults. J Am Acad Dermatol. 1999; 41(4):577-580.
3. Bhate K, Williams HC. Epidemiology of acne vulgaris. Br J Dermatol. 2013;168(3):474-485.
4. Smithard A, Glazebrook C, Williams HC. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: A community-based study. Br J Dermatol. 2001;145(2):274-279.
5. Dalgard F, Gieler U, Holm J∅, Bjertness E, Hausner S. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol. 2008;59(5):746-751.
6. Habif, TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. Philadelphia: Mosby; 2004:162-194.
7. Bolognia JL, Jorizzo JL, Rapini RP. Dermatology. 2nd ed. Spain: Mosby; 2008:496-508.
8. Zouboulis CC. Acne and sebaceous gland function. Clin Dermatol. 2004;22(5):360-366.
9. James WD, Berger T, Elston D. Andrews' Diseases of the Skin: Clinical Dermatology. 10th ed. Philadelphia, PA: Saunders; 2006:231-239.
10. Ramanathan, S, Herbert AA. Management of acne vulgaris. J Pediatr Health Care. 2011;25(5):332-337.
11. Du-Thanh A, Kluger N, Bensalleh H, Guillot B. Drug-induced acneiform eruption. Am J Clin Dermatol. 2011;12(4):233-245.
12. Akarsu S, Fetil E, Yücel F, Gül E, Güne- AT. Effi cacy of the addition of salicylic acid to clindamycin and benzoyl peroxide combination for acne vulgaris. J Dermatol. 2012;39(5):433-438.
13. Del Rosso JQ. The use of sodium sulfacetamide 10%-sulfur 5% emollient foam in the treatment of acne vulgaris. J Clin Aesthet Dermatol. 2009; 2(8):26-29.
14. Strauss JS, Krowchuk DP, Lyden JJ, et al. Guidelines of care for acne vulgaris management. J Am Acad Dermatol. 2007;56(4):651-663.
15. Tanghetti E. The evolution of benzoyl peroxide therapy. Cutis. 2008;82(suppl 5):5-11.
16. Simonart T. Newer approaches to the treatment of acne vulgaris. Am J Clin Dermatol. 2012;13(6):357-364.
17. Tripathi SV, Gustafson CJ, Huang KE, Feldman SR. Side effects of common acne treatments. Expert Opin Drug Saf. 2013;12(1):39-51.
18. Thiboutot D, Gollnick H, Bettoli V, et al. New insights into the management of acne: an update from the global alliance to improve outcomes in acne group. J Am Acad Dermatol. 2009;60(suppl 5):S1-S50.
19. Drucker CR. Update on topical antibiotics in dermatology. Dermatol Ther. 2012;25(1):6-11.
20. Fulton J, Elston DM. Acne vulgaris treament and management. 2012. http://emedicine.medscape.com/article/1069804-overview.
21. Maffeis L, Veraldi S. Minocycline in the treatment of acne: latest findings. G Ital Dermatol Venereol. 2010;145(3):425-429.
22. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: A report from a Global Alliance to Improve Outcomes in Acne. J Am Acad Dermatol. 2003;49(suppl 1):S1-S37.
23. Mastrofrancesco A, Ottaviani M, Aspite N, et al. Azelaic acid modulates the infl ammatory response in normal human keratinocytes through PPARgamma activation. Exp Dermatol. 2010;19(9):813-820.
24. Thiboutot D. Versatility of azelaic acid 15% gel in treatment of infl ammatory acne vulgaris. J Drugs Dermatol. 2008;7(1):13-16.
25. Kircik LH. Effi cacy and safety of azelaic acid (AzA gel) 15% in the treatment of post-infl ammatory hyperpigmentation and acne: A 16-week, baselinecontrolled study. J Drugs Dermatol. 2011;10(6):586-590.
26. ACZONE® Prescribing information.
27. Kircik LH. Harnessing the anti-infl ammatory effects of topical dapsone for management of acne. J Drugs Dermatol. 2010;9(6):667-671.
28. Pickert A, Raimer S. An evaluation of dapsone gel 5% in the treatment of acne vulgaris. Expert Opin Pharmacother. 2009;10(9):1515-1521.
29. Lucky AW, Maloney JM, Roberts J, et al. Dapsone gel 5% for the treatment of acne vulgaris: safety and effi cacy of long-term (1 year) treatment. J Drugs Dermatol. 2007;6(10):981-987.
30. Ghali F, Kang S, Leyden J, Shalita AR, Thiboutot DM. Changing the face of acne therapy. Cutis. 2009;83(suppl 2):4-15.
31. Del Rosso JQ. Face to face with oral isotretinoin: A closer look at the spectrum. J Clin Aesthet Dermatol. 2012;5(11):17-24.
32. Zaenglein AL, Thiboutot DM. Expert committee recommendations for acne management. Pediatrics. 2006;118(3):1188-1199.
33. Ingram JR, Grindlay DJ, Williams HC. Management of acne vulgaris: an evidence-based update. Clin Exp Dermatol. 2010;35(4):351-354.
34. Nevoralova Z, Dvorakova D. Mood changes, depression, and suicide risk during isotretinoin treatment: A prospective study. Int J Dermatol. 2013;52(2);163-168.
35. Hodgkiss-Harlow CJ, Eichenfi eld LF, Dohil MA. Effective monitoring of isotretinoin safety in a pediatric dermatology population: A novel "patient symptom survey" approach. J Am Acad Dermatol. 2011;65(3):517-524.
36. American Academy of Dermatology. AADA introduces updated isotretinoin position statement. http://www.aad.org/stories-and-news/news-releases/aada- introduces-updated-isotretinoin-osition-statement.
37. Margolis DJ, Fanelli M, Hoffstad O, Lewis JD. Potential association between the oral tetracycline class of antimicrobials used to treat acne and infl ammatory bowel disease. Am J Gastroenterol. 2010:105(12):2610-2616.
38. Toh S, Mitchell AA, Anderka M, de Jong-van den Berg LT, Hernández-Díaz S, National Birth Defects Prevention Study. Antiobiotics and oral contraceptive failure - a case-crossover study. Contraception. 2011;83(5):418-425.
39. Koopmans PC, Bos JH, de Jong van den Berg LT. Are antibiotics related to oral combination contraceptive failures in the Netherlands A case-crossover study. Pharmacoepidemiol Drug Saf. 2012;21(8):865-871.
40. Helms DE, Bredle DL, Zajic J, Jarjoura D, Brodell RT, Krishnarao I. Oral contraceptive failure rates and oral antibiotics. J Am Acad Dermatol. 1997;36(5 pt 1):705-710.
41. Shalita AR, Falcon RF, Olansky A, et al. Infl ammatory acne management with a novel prescription dietary supplement. J Drugs Dermatol. 2012;11(12):1428-1433.
42. Niren NM, Torok HM. The Nicomide Improvement in Clinical Outcomes Study (NICOS): results of an 8-week trial. Cutis. 2006;77(suppl 1)17-28.
43. Bowe WP, Joshi SS, Shalita AR. Diet and acne. J Am Acad Dermatol. 2010;63(1):124-141.
44. Dreno B, Moyse D, Alirezai M, et al. Multicenter randomized comparative double-blind controlled clinical trial of the safety and effi cacy of zinc gluconate versus minocycline hydrochloride in the treatment of infl ammatory acne vulgaris. Dermatology. 2001;203(2):135-140.
45. Adebamowo CA, Spiegelman D, Berkey CS, et al. Milk consumption and acne in teenaged boys. J Am Acad Dermatol. 2008;58(5):787-792.
46. Veith WB, Silverberg NB. The association of acne vulgaris with diet. Cutis. 2011;88(2):84-91.
47. Dréno B, Fischer TC, Perosino E, et al. Expert opinion: effi cacy of superfi cial chemical peels in active acne management - what can we learn from the literature today Evidence-based recommendations. J Eur Acad Dermatol Venereol. 2011;25(6):695-704.
48. Jung JY, Hong JS, Ahn CH, Yoon JY, Kwon HH, Suh DH. Prospective randomized controlled clinical and histopathological study of acne vulgaris treated with dual mode of quasi-long pulse and Q-switched 1064-nm Nd:YAG laser assisted with a topically applied carbon suspension. J Am Acad Dermatol. 2012;66(4):626-633.